IXICO plc is engaged in the provision of clinical trials services to the pharmaceutical industry. The Company provides its technologies to those involved in researching and treating diseases, such as dementia. The Company's digital health technology consists of three product platforms, which include TrialTracker, Assessa and MyBrainBook. Its TrialTracker image data and query management platform serves its clinical trials business. TrialTracker is used in clinical trials run by IXICO and forms the framework for its medical device, Assessa. The Company's Assessa is its decision support tool for diagnosing dementia and Alzheimer's disease. Assessa is also used in other neurological disorders in which the measurement of hippocampal volume can be used, such as schizophrenia. Its MyBrainBook provides support to dementia patients post-diagnosis. MyBrainBook is a digital health hub delivering facilitated support to patients and their carers.